Skip to search.
 All Ordinaries Down 1.97%
Streaming
Ticker Tape: On

More On PGL.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Progen Pharmaceuticals Limited (PGL.AX)

-ASX

0.22 0.00(0.00%) 10:18

Add to Portfolio
Prev Close:0.22
Open:0.22
Bid:0.22
Ask:0.24
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.22 - 0.22
52wk Range:0.12 - 0.30
Volume:16,334
Avg Vol (3m):6,746
Market Cap:5.31M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Comparison

Symbol% ChgMkt Cap
PGL.AX 0.00%5.31M
RHHBYN.MXUp 0.14%2.66T
SHP.LDown 1.11%11.75B
SUNPHARMA.NSDown 0.23%1.04T
GILD.MXDown 0.83%1.06T
» More Competitors

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.53
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progen Pharmaceuticals Limited, a biotechnology company, engages in the discovery, research, and development of biopharmaceutical therapeutics for the treatment of human diseases in Australia and the United States. View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback